Phosphoglycerate dehydrogenase: Potential therapeutic target and putative metabolic oncogene

Journal of Oncology

Volumn 2014, Issue , 2014, Pages

  Zogg, Cheryl K ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOGLYCERATE DEHYDROGENASE; PHOSPHOGLYCERATE KINASE; PYRUVIC ACID DERIVATIVE; SERINE;

BREAST CANCER; CANCER CELL; CARCINOGENESIS; DRUG TARGETING; ENZYME METABOLISM; EXPERIMENTAL MODEL; GLYCOLYSIS; HUMAN; METABOLISM; NONHUMAN; ONCOGENE; PROTEIN EXPRESSION; REVIEW; TUMOR SUPPRESSOR GENE;

EID: 84919797513     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2014/524101     Document Type: Review

References (44)

1. A. R. Mullen and R. J. DeBerardinis, "Genetically-defined metabolic reprogramming in cancer," Trends in Endocrinology &Metabolism, vol. 23, no. 11, pp. 552-559, 2012
2. D. Hanahan and R. A. Weinberg, "The hallmarks of cancer," Cell, vol. 100, no. 1, pp. 57-70, 2000
3. O. Warburg, "On the origin of cancer cells," Science, vol. 123, no. 3191, pp. 309-314, 1956
4. O. Warburg, K. Posener, and E. Negelein, "UeberdenStoffwechsel der Tumoren," Biochemische Zeitschrift, vol. 152, pp. 319-344, 1924
5. R. J. Deberardinis, "Serine metabolism: some tumors take the road less traveled," Cell Metabolism, vol. 14, no. 3, pp. 285-286, 2011
6. E. Mullarky, K. R. Mattaini,M. G. VanderHeiden, L. C. Cantley, and J. W. Locasale, "PHGDH amplification and altered glucose metabolism in human melanoma," Pigment Cell and Melanoma Research, vol. 24, no. 6, pp. 1112-1115, 2011
7. M. G. V. Heiden, L. C. Cantley, and C. B. Thompson, "Understanding the warburg effect: the metabolic requirements of cell proliferation," Science, vol. 324, no. 5930, pp. 1029-1033, 2009
8. J. W. Locasale, A. R. Grassian, T. Melman et al., "Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis," Nature Genetics, vol. 43, no. 9, pp. 869-874, 2011
9. D. Astuti, F. Latif, A. Dallol et al., "Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma," American Journal of Human Genetics, vol. 69, no. 1, pp. 49-54, 2001
10. B. E. Baysal, R. E. Ferrell, J. E. Willett-Brozick et al., "Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma," Science, vol. 287, no. 5454, pp. 848-851, 2000
11. S. Niemann and U. Muller, "Mutations in SDHC cause autosomal dominant paraganglioma, type 3," Nature Genetics, vol. 26, no. 3, pp. 268-270, 2000
12. A.-P. Gimenez-Roqueplo, J. Favier, P. Rustin et al., "The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway," The American Journal of Human Genetics, vol. 69, no. 6, pp. 1186-1197, 2001
13. I. P. M. Tomlinson, N. A. Alam, A. J. Rowan et al., "Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer the multiple leiomyoma consortium," Nature Genetics, vol. 30, no. 4, pp. 406-410, 2002
14. M. A. Selak, S. M. Armour, E. D. MacKenzie et al., "Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF prolyl hydroxylase," Cancer Cell, vol. 7, no. 1, pp. 77-85, 2005
15. R. B. Hamanaka and N. S. Chandel, "Targeting glucosemetabolism for cancer therapy,"The Journal of Experimental Medicine, vol. 209, no. 2, pp. 211-215, 2012
16. K. Snell, "Enzymes of serine metabolism in normal, developing and neoplastic rat tissues," Advances in Enzyme Regulation, vol. 22, pp. 325-400, 1984
17. K. Snell, "Enzymes of serine metabolism in normal and neoplastic rat tissues," Biochimica et Biophysica Acta-General Subjects, vol. 843, no. 3, pp. 276-281, 1985
18. K. Snell and G. Weber, "Enzymic imbalance in serine metabolism in rat hepatomas," Biochemical Journal, vol. 233, no. 2, pp. 617-620, 1986
19. K. Snell, Y. Natsumeda, and G. Weber, "The modulation of serine metabolism in hepatoma 3924A during different phases of cellular proliferation in culture," Biochemical Journal, vol. 245, no. 2, pp. 609-612, 1987
20. K. Snell, Y. Natsumeda, J. N. Eble, J. L. Glover, and G. Weber, "Enzymic imbalance in serine metabolism in human colon carcinoma and rat sarcoma," British Journal of Cancer, vol. 57, no. 1, pp. 87-90, 1988
21. R. Possemato, K. M. Marks, Y. D. Shaul et al., "Functional genomics reveal that the serine synthesis pathway is essential in breast cancer," Nature, vol. 476, no. 7360, pp. 346-350, 2011
22. H. M. Cho, D. Y. Jun, M. A. Bae, J. D. Ahn, and Y. H. Kim, "Nucleotide sequence and differential expression of the human 3-phosphoglycerate dehydrogenase gene," Gene, vol. 245, no. 1, pp. 193-201, 2000
23. S. Pollari, S.-M. Käkönen, H. Edgren et al., "Enhanced serine production by bone metastatic breast cancer cells stimulates osteoclastogenesis," Breast Cancer Research and Treatment, vol. 125, no. 2, pp. 421-430, 2011
24. J. Liu, S. Guo, Q. Li et al., "Phosphoglycerate dehydrogenase induces glioma cells proliferation and invasion by stabilizing forkhead box M1," Journal of Neuro-Oncology, vol. 111, no. 3, pp. 245-255, 2013
25. Z. Jing,W. Heng,D. Aiping,Q. Yafei, and Z. Shulan, "Expression and clinical significance of phosphoglycerate dehydrogenase and squamous cell carcinoma antigen in cervical cancer," International Journal ofGynecological Cancer, vol. 23,no. 8, pp. 1465-1469, 2013
26. S. Noh, D. H. Kim,W. H. Jung, and J. S. Koo, "Expression levels of serine/glycine metabolism-related proteins in triple negative breast cancer tissues," Tumor Biology, vol. 35, no. 5, pp. 4457-4468, 2014
27. J. L. Davis, H. J. Fallon, and H. P. Morris, "Two enzymes of serine metabolism in rat liver and hepatomas," Cancer Research, vol. 30, no. 12, pp. 2917-2920, 1970
28. Y. Achouri, M. H. Rider, E. Van Scharingen, and M. Robbi, "Cloning, sequencing and expression of rat liver 3-phosphoglycerate dehydrogenase," Biochemical Journal, vol. 323, no. 2, pp. 365-370, 1997
29. D. A. Fell and K. Snell, "Control analysis of mammalian serine biosynthesis. Feedback inhibition of the final step," Biochemical Journal, vol. 256, no. 1, pp. 97-101, 1988
30. D. A. Walsh and H. J. Sallach, "Comparative studies on the pathways for serine biosynthesis in animal tissues," Journal of Biological Chemistry, vol. 241, no. 17, pp. 4068-4076, 1966
31. R. Beroukhim, C. H. Mermel, D. Porter et al., "The landscape of somatic copy-number alteration across human cancers," Nature, vol. 463, no. 7283, pp. 899-905, 2010
32. M. J. Van De Vijver, Y. D. He, L. J. Van 'T Veer et al., "A geneexpression signature as a predictor of survival in breast cancer," The New England Journal ofMedicine, vol. 347, no. 25, pp. 1999-2009, 2002
33. D. J. Slamon, G. M. Clark, S. G. Wong, W. J. Levin, A. Ullrich, and W. L. McGuire, "Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene," Science, vol. 235, no. 4785, pp. 177-182, 1987
34. S. Seton-Rogers, "Metabolism: flexible flux," Nature Reviews Cancer, vol. 11, no. 9, article 621, 2011
35. M. A. Nikiforov, S. Chandriani, B. O'Connell et al., "Afunctional screen forMyc-responsive genes reveals serine hydroxymethyltransferase, a major source of the one-carbon unit for cell metabolism," Molecular & Cellular Biology, vol. 22, no. 16, pp. 5792-5800, 2002
36. S. C. Kalhan and R. W. Hanson, "Resurgence of serine: an often neglected but indispensable amino acid," The Journal of Biological Chemistry, vol. 287, no. 24, pp. 19786-19791, 2012
37. J. Luo, "Cancer's sweet tooth for serine," Breast Cancer Research, vol. 13, no. 6, p. 317, 2011
38. I. Amelio, E. K. Markert, A. Rufini et al., "p73 regulates serine biosynthesis in cancer," Oncogene, vol. 33, no. 42, pp. 5039-5046, 2013
39. Y. Ye, Y. Zhou, L. Zhang et al., "EBV-miR-BART1 is involved in regulating metabolism-associated genes in nasopharyngeal carcinoma," Biochemical and Biophysical Research Communications, vol. 436, no. 1, pp. 19-24, 2013
40. L. Ma, Y. Tao, A. Duran et al., "Control of nutrient stressinduced metabolic reprogramming by PKC in tumorigenesis," Cell, vol. 152, no. 3, pp. 599-611, 2013
41. J. Y. Kim, T. Valencia, S. Abu-Baker et al., "C-Myc phosphorylation by PKC represses prostate tumorigenesis," Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 16, pp. 6418-6423, 2013
42. M. Zhang, C. Wan, B. Ji et al., "Proteome alteration of U251 human astrocytoma cell after inhibiting retinoic acid synthesis," Molecular and Cellular Biochemistry, vol. 323, no. 1-2, pp. 185-193, 2009
43. M. H. Al-Dhaheri, Y. M. Shah, V. Basrur, S. Pind, and B. G. Rowan, "Identification of novel proteins induced by estradiol, 4-hydroxytamoxifen and acolbifene in T47D breast cancer cells," Steroids, vol. 71, no. 11-12, pp. 966-978, 2006
44. J. Chen, F. Chung, G. G. Yang et al., "Phosphoglycerate dehydrogenase is dispensable for breast tumor maintenance and growth," Oncotarget, vol. 4, no. 12, pp. 2502-2511, 2013.